● Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

Condition: Relapsing Multiple Sclerosis · Multiple Sclerosis · Sponsor: TG Therapeutics, Inc.

PhaseN/A

Planned participants2000

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

This description comes directly from the study's public registry record.

Talk to the study team

TG Therapeutics Clinical Support Team · 1-877-575-8489 · clinicalsupport@tgtxinc.com

Always discuss trial participation with your own doctor first.

Locations (91)

TG Therapeutics Investigational Trial Site	Birmingham, Alabama, United States	Recruiting
TG Therapeutics Investigational Trial Site	Huntsville, Alabama, United States	Recruiting
TG Therapeutics Investigational Trial Site	Mobile, Alabama, United States	Recruiting
TG Therapeutics Investigational Trial Site	Gilbert, Arizona, United States	Recruiting
TG Therapeutics Investigational Trial Site	Phoenix, Arizona, United States	Recruiting
TG Therapeutics Investigational Trial Site	Scottsdale, Arizona, United States	Recruiting
TG Therapeutics Investigational Trial Site	Fresno, California, United States	Recruiting
TG Therapeutics Investigational Trial Site	Newport Beach, California, United States	Recruiting
TG Therapeutics Investigational Trial Site	Orange, California, United States	Recruiting
TG Therapeutics Investigational Trial Site	West Hollywood, California, United States	Recruiting
TG Therapeutics Investigational Trial Site	Aurora, Colorado, United States	Recruiting
TG Therapeutics Investigational Trial Site	Basalt, Colorado, United States	Recruiting

+ 79 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06433752